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Abstract—Objective: The aim of the study was to show if
pulse rise times (PRTs) extracted from photoplethysmographic
(PPG) pulse waves (PWs) have an association with peripheral
arterial disease (PAD) or its endovascular treatment, percuta-
noeus transluminal angioplasty (PTA) of the superficial femoral
artery. Methods: Lower and upper limb PPG PWs were recorded
and analyzed from 24 patients who suffered from PAD. The
measurements were conducted before and after the treatment,
and one month later by using transmission-mode PPG-probes
placed in the index finger and second toe. Ankle-to-brachial
pressure index (ABI) and toe pressures were used as references
in clinical patient measurements. PRTs, i.e. the time from the
foot point to the peak point of the PW, were extracted from
the PWs and compared bilaterally. The results from the PAD-
patients were also compared with 31 same-aged and 34 younger
control subjects. Results: Statistically significant differences were
found between the pre-treatment PRTs of the treated limb of
the PAD-patients and the same-aged control subjects (p < 10−9,
Mann-Whitney U-test). The changes in the PRT of the treated
lower limb were observed immeadiately after the PTA (p < 0.001,
Student’s t-test), and after one month (p < 0.0005), whereas
the PRTs of the non-treated lower limb and upper limb did
not indicate changes between different examinations. Conclusion:
Results show that a PRT greater than 240 ms indicates PAD-
lesions in the lower limb. Significance: This proof-of-concept
study suggests that the PRT could be an effective and easy-
to-use indicator for PAD and monitoring the effectiveness of its
treatment.
Index Terms—Atherosclerosis, Photoplethysmography, Periph-
eral arterial disease, Pulse rise time, Pulse wave measurements.
I. INTRODUCTION
Peripheral arterial disease (PAD) is a specific form of
atherosclerosis affecting mainly the lower limbs. It can be
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either subclinical and asymptomatic or cause several symp-
toms such as intermittent claudication or in severe cases
rest pain, which is typically a manifestation of critical
limb ischemia. PAD is considered as a risk factor of acute
cardiovascular events such as stroke or myocardial infarction
and generally as an indicator of polyvascular disease, i.e.
presence of atherosclerosis in two or more vascular beds.
In addition to surgery, PAD is commonly treated by means
of percutaneous transluminal angioplasty (PTA) which is a
minimally invasive endovascular procedure for expanding the
stenosed artery. The PTA initiates the revascularization which
in most cases induces regenerative histological changes in the
arteries. The patency rates after the femoropopliteal PTA are
reported to vary from 75 %–97 % and 60 %–84 % for one- and
two-year follow-up times [1], respectively. In order to ensure
the technical success of the PTA, the patients are typically re-
examined with the measurement of ankle-to-brachial pressure
index (ABI) after one-month follow-up period.
The early diagnosis of the PAD is challenging due to its
subclinical course. The measurement of ABI is considered as
a gold standard even though its performance is challenged by
diabetes and mediasclerosis [2]–[4] and even though it has
found to have varying sensitivity and specificity [5]. Imaging
based angiograms provide more precise information on the
PAD lesions, but they are not suitable for screening studies
because of their high costs, nephrotoxicity of the contrast
agents and radiation exposure.
Photoplethysmography (PPG) is an optical and non-invasive
technique for measuring the peripheral blood volume changes.
A PPG probe consists of a light source and a photodetector.
The light source illuminates the tissue, and the intensity of the
reflected or transmitted light is observed by the photodetector.
The intensity of the reflected or transimitted light depends on
the optical properties of the tissue, including the amount of
blood. It provides information on multiple biomedical param-
eters, such as heart rate, blood oxygen saturation, respiratory
rate, and the condition of the vasculature [6], and could
also provide a non-invasive and simple alternative for finding
the PAD lesions. Earlier studies [6]–[11] have shown that
different kinds of PPG-based lower limb pulse transit times
(PTTs) are affected mainly by aging and the existence of
PAD, but also by systolic blood pressure and height. Two
of the major contributors, aging and PAD, affect the PTT in
different directions: aging decreases the PTT but the existence
of PAD lesions increases it [12]. Pulse rise time (PRT) is
a time difference between two reference points found from
the individual PPG PWs, i.e. peak and foot points. Allen et
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2al. have reported differences in lower limb PPG-based PRTs
between healthy subjects and PAD patients [6], [8], [9], but
the authors are not aware of any prior study reporting the
effects of PTA-treatment to PRT. In this proof-of-concept
study, we investigate how the photoplethysmographic PRT
changes as a result of the PTA procedure and if the PRTs
could be a useful parameter to monitor patients’ peri- and
post-treatment response to PTA. We also study if the PRTs
of the lower limb in patients with symptomatic PAD differ
from the PRTs in the contralateral lower limb and from the
lower limb PRTs of healthy subjects. We hypothesize that the
stenoses in the arterial pathway increase the flow resistance,
causing a low-pass filter-type response and delay in the PRT,
whereas a successful PTA of the SFA decreases the resistance
and changes the PRT towards healthier level.
II. MATERIALS AND METHODS
A. Study subjects
Altogether 89 Caucasian subjects were examined for the
study. The patient measurements were conducted in two clini-
cal studies (S1 and S2). The pulse wave (PW) signals of study
S1 were recorded from 27 patients undergoing PTA for the
superficial femoral artery (SFA) in 2016–2017. Three of them
were excluded for the following reasons: research personnel
unavailable at the follow-up visit, a patient was found to be
unsuitable for PTA during the imaging and extremely low
peripheral perfusion preventing the computation of PPG-based
parameters. In study S1, 14 left and 12 right lower limbs
were treated, including 2 patients with bilateral treatment.
More detailed data on the study subjects is shown in Table
I. The majority of the PAD patients suffered from intermittent
claudication which is a typical symptom for PAD. In addition,
most of the PAD patients had typical risk factors of atheroscle-
rosis, such as dyslipidemia, diabetes, and arterial hypertension.
Because almost all of the subjects having these diagnosed
diseases had medication, the effects of the medication intended
against atherosclerosis-promoting symptoms were not possible
to analyze separately.
The inclusion criteria for study S1 were abnormal ABI
reading, i.e. ABI<0.9 or ABI>1.3, relevant symptoms, stenosis
in the SFA based on magnetic resonance angiography (MRA)
and referral to the PTA of the SFA. The presence of a
pacemaker and a possible risk that the study interferes the
patient’s treatment were considered as exclusion criteria. All
patients except one met the criterion ABI<0.9 in study S1, and
only one of the included patients had a measured pre-treatment
ABI higher than 1.3. Fifteen non-treated lower limbs out of
22 (68 %) had the ABI value outside the normal range at least
in one of the pre- or post-treatment ABI measurements. More
detailed distributions of the PAD patients’ ABI readings are
shown in Table II. Pre-treatment (measured during a visit at the
outpatient clinic before the PTA) and post-treatment (follow-
up visit) ABI and toe pressure measurements were routinely
performed and used as references in the study.
Altogether 28 at least 65-year-old control subjects having
normal ABI were examined in study S2 in 2015. In addition
Table I
DATA DESCRIBING THE STUDY SUBJECT POPULATION. THE VALUES ARE
PRESENTED AS MEDIAN (1ST QUARTILE–3RD QUARTILE)
Study S1 Study S2
Group PTA-patients Old Middle-aged Young
(n=24) (n=31) (n=15) (n=19)
Age (years) 72 (68–76) 71 (67–77) 58 (54–62) 28 (25–33)
Heart rate (bpm)
pre-PTA 65.3 (58.1–72.7) 66.1 59.7 65.3
post-PTA 64.2 (58.1–72.5) (58.5–71.8) (55.1–65.2) (58.0–70.3)
follow-up visit 62.7 (56.7–73.6)
Treated lower limbs: 26
- -
ABI, pre-treatment 0.61 (0.50–0.75)
follow-up visit 0.96 (0.82–1.04)
change 0.24 (0.16–0.41) 1.10
Non-treated lower limbs: 22 (1.06–1.22)#
ABI, pre-treatment 0.88 (0.75–1.02)
follow-up visit 0.94 (0.72–1.08)
change 0.02 (-0.07–0.25)
Toe pressure, treated limb:
- - -pre-treatment (mmHg) 59 (42–86)follow-up visit (mmHg) 95 (76–122)
change (mmHg) 22 (7–41)
Toe pressure, non-treated limb:
- - -pre-treatment (mmHg) 76 (53–118)follow-up visit (mmHg) 100 (66–122)
change (mmHg) 6 (-24–24)
Men 16 (66.7 %) 12 (38.7 %) 14 (93.3 %) 18 (94.7%)
Diabetes 11 (45.8 %) 1 (3.2 %) 1 (6.7 %) 1 (5.3 %)
Dyslipidemia 22 (91.7 %) 5 (16.1 %) 0 (0 %) 0 (0 %)
History of smoking 11 (45.8 %) 7 (22.6 %) 0 (0 %) 0 (0 %)
Rheumatoid arthritis 3 (12.5 %) 5 (16.1 %) 0 (0 %) 1 (5.3 %)
Angina pectoris 1 (4.2 %) 1 (3.2 %) 0 (0 %) 0 (0 %)
Critical limb ischemia 4 (16.7 %) 0 (0 %) 0 (0 %) 0 (0 %)
Intermittent claudication 22 (91.7 %) 0 (0 %) 0 (0 %) 0 (0 %)
Hemiplegia 3 (12.5 %) 0 (0 %) 0 (0 %) 0 (0 %)
Hypertension 19 (79.2 %) 7 (22.6 %) 0 (0 %) 0 (0 %)
Ischemic stroke 1 (4.2 %) 0 (0 %) 0 (0 %) 0 (0 %)
Carotid stenosis 2 (8.3 %) 0 (0 %) 0 (0 %) 0 (0 %)
Coronary artery disease 7 (29.2 %) 0 (0 %) 0 (0 %) 0 (0 %)
Coronary thrombosis 5 (20.8 %) 0 (0 %) 0 (0 %) 0 (0 %)
Cardiac failure 5 (20.8 %) 1 (3.2 %) 0 (0 %) 0 (0 %)
Arrhytmia 4 (16.7 %) 2 (6.5 %) 0 (0 %) 0 (0 %)
Renal failure 4 (16.7 %) 0 (0 %) 0 (0 %) 0 (0 %)
#: p < 0.0005 for all the ABI-distribution comparisons of old healthy vs. the
pre-treatment condition of treated limb, the follow-up visit condition of treated limb,
the pre-treatment condition of non-treated limb, and the follow-up visit condition of
treated limb (2-sided Mann-Whitney U-test).
Table II
DISTRIBUTIONS OF ABI READINGS FOR PAD PATIENTS.
Treated limb Non-treated limb
pre-PTA follow-up visit pre-PTA follow-up visit
ABI<0.5 5 (19.2%) 2 (7.7%) 1 (4.6%) 0 (0.0%)
ABI<0.7 16 (69.6%) 5 (19.2%) 3 (13.6%) 5 (22.7%)
ABI<0.9 24 (92.3%) 10 (38.4%) 12 (54.6%) 9 (40.9%)
0.9≤ABI≤1.3 1 (3.9%) 14 (53.9%) 9 (40.9%) 11 (50.0%)
ABI>1.3 1 (3.9%) 2 (7.7%) 1 (4.6%) 2 (9.1%)
to clinical patient measurements, 37 volunteer healthy 22–71-
year-old control subjects were examined in 2013–2017 in non-
clinical environment in order to see if aging affects the PRTs.
These measurements were conducted in Tampere University
of Technology (21 subjects) and in University of Oulu (16
subjects). In these datasets, 3 subjects being at least 65 years
of age were added and handled as a part of the clinical control
subject group (old subjects). The rest of these 37 test subjects
were divided into groups of 19 young (less than 40-year-old)
and 15 middle-aged (40–64-year-old) subjects.
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Figure 1. Examples of raw (a) and filtered (b) lower limb PWs as well as extracted PRTs for treated and non-treated lower limb before the PTA.
B. Measurement hardware
In studies S1 and S2 as well as in the measurements
conducted in Tampere University of Technology, the measure-
ment data was collected using transmission mode PPG-probes
(S0010A, Shenzhen Med-link, China) having an excitation
wave length of 905 nm connected into a synchronous wireless
body sensor network (WBSN) presented in [13]. The pass-
band of the PPG-amplifier of the WBSN was from 150 mHz to
240 Hz. A photoplethysmograph based on the phase-sensitive
technique and transmission mode PPG-probes containing 940
nm light emitting diodes (LEDs) and photodiodes (BPW34,
Vishay Semiconductors, USA) were used in the measurements
conducted in University of Oulu [14]. The sampling frequen-
cies were 500 Hz and 1000 Hz for WBSN and phase-sensitive
PPG, respectively.
C. Sensor placement
With the PAD-patients, the PPG probes were placed on
the index finger and both second toes for recording blood
volume PW-signals. The test subjects were in supine position
during the measurements. In study S1, the measurements were
conducted during the pre-, peri-, and post-treatment phases
of the PTA and during the follow-up visit after one month
(median 33 days, IQR (30 days–36 days)). The sensors were
placed before the normal preparation of the PTA and were
removed within 5–10 minutes after the PTA. The duration of
the measurement was approximately 15 minutes in study S2
and in the measurements conducted outside the hospitals.
D. Pulse rise times
PRT was defined as the time from the foot point to the peak
point of the PW (Fig. 1). Before the determination of the foot
and peak points, the PW-signals were lowpass-filtered with
a finite impulse response filter having a cut-off-frequency of
10 Hz, transition band of 10 Hz–12 Hz, pass-band ripple of
0.05 dB, and a stop-band attenuation of 100 dB [15] using
forward-backward filtering. After filtering, the end-point fixed
linear trend was removed from each detected PW. Both filtered
and raw signal examples on pre-treatment PWs are shown in
Fig. 1 for treated and non-treated lower limb. The PAD-lesions
are seen as attenuation of high-frequency features of PW, such
as rounded sharp edges and a misssing dicrotic notch [8], [9],
[11], [16]. As seen in Fig 1, the PAD-lesions may also change
the morphology of the PW towards a sinusoidal wave and
cause delayed arrival compared with a healthier contralateral
limb [8], [9], [11].
The PRTs were computed as an average of at least one
minute long recording. For the PAD patients, the lower and
upper limb PRTs were extracted as immediate pre-treatment
PRT (tbefore), immediate post-treatment PRT (tafter), and PRT
in the follow-up visit (tfollow−up). The differences between
different measurement events were computed between post-
and pre-treatment values as tab = tafter − tbefore, between
follow-up visit and pre-treatment values as tfb = tfollow−up −
tbefore, and between follow-up visit and post-treatment values
as tfa = tfollow−up − tafter.
E. Statistical methods
Before comparing the results found for different study
groups, the data normality was checked by using one-sample
Kolmogorov-Smirnov test. Since all the rise time distribu-
tions were not normally distributed, non-parametric two-sided
Mann-Whitney U-tests were implemented for comparing the
control subjects’ and the PAD patients’ results, for comparing
the PAD patients’ results in different stages of operation, and
for comparing the PAD patients’ pre-treatment PRT distri-
butions for treated and non-treated lower limbs. As all the
differences between different measurement events (before the
treatment, after the treatment, and follow-up visit) turned out
to be normally distributed, their deviation from zero was
tested by implementing Student’s paired two-sided t-tests. The
4differences in the PRT values between different phases of
the PTA treatment were not normally distributed, so non-
parametric two-sided sign tests were implemented. P-values
less than 0.05 were considered statistically significant. The
performance of the PRTs in classifying the lower limbs into
diseased or non-diseased was evaluated by means of receiver
operating characteristic (ROC) curve analysis. In addition,
the agreement between the ABI and PRT were evaluated by
estimating Pearson’s correlation coefficients for both absolute
ABI and PRT as well as their change as a result of the PTA
treatment.
Since vascular patients typically have multiple cardiovas-
cular risk factors, multiple linear regression analysis was
performed for both upper and lower limb PRTs of the PAD-
patients, and for the old, middle-aged and young control
subjects in order to see which factors affect the PRTs. In order
to avoid the distortion of the results caused by the risk factors
being present only with few individual test subjects, only the
predictors being present with at least 5 test subjects were taken
into account. For the PAD-patients, the analysis was performed
only for the pre-treatment values. Multiple linear regression
analysis was implemented also for the changes in PRT having
PTA and change in heart rate as predictors in order to check
if the changes in the heart rate explain the changes in the PRT
between a pre-treatment condition and a follow-up visit.
F. Ethics and patient safety
The patient measurements were approved by the local
ethical review board of the hospital district (R14096 and
R15107), and the Finnish National Supervisory Authority of
Health and Welfare (Valvira, IDs 272 and 309). The study S1
was registered at ClinicalTrials.gov (ID: NCT02725307).
III. RESULTS
A. Differences between study groups
The distributions of the lower limb PRTs for different study
groups are presented in Fig. 2. The pre-treatment PRTs of the
treated lower limb were clearly greater than the PRTs of the
lower limbs of the group of old control subjects (p < 10−9)
as presented in Fig 2. In addition, the differences in the
lower limb PRT distributions between different-aged control
groups were found to be small (Fig 2). The pre-treatment
rise time distributions for treated and non-treated lower limbs
were strongly overlapping, even though statistically signicant
differences were found between them (p ≈ 0.017). At least a
small difference was expected despite possible systemic effects
of atherosclerosis since the pre-treatment ABI and toe pressure
distributions were not equal (Table I). A small difference
was also observed in the index finger PPG PRTs between
the group of the old control subjects and the PAD-patients
(p ≈ 0.015, Fig. 3) even though these distribtions were also
strongly overlapping. In the index finger PRTs, the differences
between the youngest group and older control groups were
greater than in case of lower limb PRTs.
The ROC curves are shown in Fig. 4 in order to demonstrate
the classification performance of the PRT. They are drawn
Yo
un
g
Mi
dd
le-
ag
ed Old
Be
for
e t
rea
tm
en
t
Aft
er 
tre
atm
en
t
Fo
llow
-up
 vis
it
Be
for
e t
rea
tm
en
t
Aft
er 
tre
atm
en
t
Fo
llow
-up
 vis
it
Pu
ls
e 
ris
e 
tim
e 
(m
s)
100
150
200
250
300
350
400
450
500 p <  10-5
p <  10-9
p : 0.017
p < 0.001
p 
:
 
0.
18
PAD
patients:
Treated
lower limb
PAD patients:
Non-treated
lower limb
Control
subjects
Distributions of the pulse rise times of toe PPG
Figure 2. Distributions of the lower limb PRTs for different subject groups
and treatment phases. The p-values are for two-sided Mann-Whitney U-test.
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Figure 3. Distributions of the upper limb (index finger) PRTs for different
subject groups and treatment phases. The p-value is for two-sided Mann-
Whitney U-test.
for two different situations: 1) the treated limb of the PAD-
patients before the PTA vs. old healthy controls, and 2) the
treated lower limb before the PTA vs. the non-treated lower
limb before the PTA. The areas under curve (AUC) of 0.986
and 0.706 were obtained for the two situations, respectively.
Even though the non-treated lower limb is less symptomatic
than the contralateral limb, it does not mean that it does not
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Figure 4. Receiver operating characteristic (ROC) curves for two situations:
1) the treated limb of PAD patients before the PTA vs. old healthy controls,
and 2) treated lower limb before the PTA vs. non-treated lower limb before
the PTA.
have any atherosclerotic PAD lesions due to the systemic
nature of atherosclerosis. This is seen as the relatively low
AUC for the distinction of treated and non-treated limb based
on PRT. The partition values of 250 ms and 232 ms provide
the sensitivities of 0.875 and 1.00 with specificities of 0.967
and 0.903, respectively, for the comparison between healthy
old controls and PAD patients. Thus, according to our results
based on Caucasian subjects, the lower limb PRT greater than
approximately 240 ms is a sign of possbile PAD lesions in
that lower limb.
B. Dependence between ABI and PRT
ABI and PRT values in different study groups and PAD
patients at different phases are shown as a scatter plot in Fig. 5.
Also the regression lines and Pearson’s correlation coefficients
are shown in Fig. 5 based on four different combinations
of source data. A linear dependence between ABI and PRT
cannot be assumed for ABI-values higher than 1.3 which
indicates incompressible arteries. The normal range for ABI
is 0.9–1.3, so the ABI-values higher than 1.3 were excluded.
A dataset consisting of the old control subjects and the
pre-treatment data of the PAD patients’ treated limb yielded
a correlation of −0.81 (−0.89. . .−0.69 (95% confidence in-
terval), p < 10−11). This evaluates how the PRT correlates
with ABI in non-treated subjects and suggests that the PRT
could discriminate at least the most extreme PAD lesions from
healthy subjects. A correlation of −0.64 (−0.78. . .−0.42, p <
10−5) was found for a dataset consisting of PAD patients’ pre-
treatment and follow-up visit results, and this describes how
the ABI and PRT correlate in a data containing the treatment
response. To estimate the overall dependence between the ABI
and PRT, a correlation of −0.58 (−0.70. . .−0.43, p < 10−9)
was found for the dataset consisting all the datapoints in Fig. 5.
The least dependence (r = −0.29, −0.01. . .−0.53, p < 0.05)
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Figure 5. Comparison between ABI and PRT, grouped by different study
groups. Also the regression lines based on different data are shown with
Pearson’s correlation coefficients (r) and p-values.
between the ABI and PRT was observed in a dataset consisting
the old control subjects and the pre-treatment data from the
non-treated limb. In this dataset, the majority of the ABI-
readings was in a narrower range than in the other datasets
which may explain the poorer dependence.
C. Changes caused by PTA
Fig. 2 shows that the PRTs at pre-treatment, immediate post-
treatment, and follow-up visit conditions of the treated limb
are strongly overlapping, and there are even no statistically
significant difference between the pre-treament and immediate
post-treatment conditions (p ≈ 0.18). This is because the
average or median change in PRT is relatively small with
respect to its large between-subject variance.
However, at the individual level, there are group-wide
consistent decreases in the PRTs of the treated limb as a result
of the PTA. Clear differences are observed by using paired 2-
sided Student’s t-tests for testing if the normally distributed
differences between different conditions deviate from zero.
Fig. 6 shows the distributions for paired changes between
different situations, i.e. 1) immediately after and before the
PTA, 2) follow-up visit and before the PTA, and 3) follow-
up visit and immediately after the PTA. The differences are
shown for both treated and non-treated lower limb as well as
for the upper limb (index finger). The results in Fig. 6 show
statistically significant differences in the treated lower limb:
1) −33.9 ms (−74.6 ms. . .−4.2 ms) (median (25%. . . 75%
quartiles)), p < 0.0005, 2) −64.7 ms (−137.3 ms. . .−20.1
ms), p < 0.0005, and 3) −59.0 ms (−110.5 ms. . .−15.6 ms),
p < 0.001 for the changes between immediate pre- and post-
treatment, pre-treatment and follow-up visit, and immediate
post-treatment and follow-up visit conditions, respectively. The
signals recorded from non-treated lower limb and index finger
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Figure 7. Changes in a lower limb PRT as a function of changes in the ABI.
do not show consistent or significant differences in either
direction. The results in Fig. 6 show that the PTA causes
immediate changes in PRTs in the treated limb and the changes
continue during the follow-up period. The continuation of
the change is most probably due to histological remodeling
of the vasculature in the treated lower limb initiated by the
revascularization. This is supported by the lack of consistent
changes in the non-treated lower limb and in the index finger
PRTs. Even though the PRTs of the treated lower limb change
towards healthier direction, differences still remain between
the old control subjects and the follow-up visit condition of
the treated limb (Fig. 2, p < 10−5).
Changes in the PRT as a function of changes in the ABI
are shown in Fig. 7 for both treated and non-treated lower
limbs. Pearson’s correlation coefficient between the change in
lower limb PRT and ABI is r = −0.595 (p < 5 · 10−5, 95%-
confidence interval −0.758 . . .− 0.362). The Pearson’s linear
correlation between the PRT and the other reference parameter,
toe pressure, was less significant r = −0.348 (p = 0.026,
95%-confidence interval −0.592 . . . − 0.046) which was the
case also with the correlation between the reference parameters
(ABI and toe pressure, r = 0.327, p = 0.033, 95%-confidence
interval 0.033 . . . 0.568).
The inserted instrumentation did not cause significant
changes: the median (interquartile range) changes in PRT
values were 6.9 ms (-3.4 ms–17.6 ms, p ≈ 0.08) and -
6.0 ms (-12.2 ms–1.6 ms, p ≈ 0.42) for 1) pre-treatment
situation vs. all the endovascular instruments inserted in the
SFA, and 2) immediately after the last balloon angioplasty all
the endovascular instruments in the SFA vs. immediate post-
treatment condition, respectively.
D. Multiple linear regression
For the upper limb PRTs, the age, heart rate and smoking are
statistically significant predictors. With lower limb PRTs, the
PAD is a clearly more significant predictor than age, heart rate,
other cardiovascular disorders or symptoms concomitantly
present in the PAD-patients. The visually observed stronger
age dependence of the upper limb (Fig. 3) in comparison
with the lower limb (Fig. 2) PRT supports the results of the
multiple linear regression analysis. Table IV shows the results
of multiple linear regression analysis for the changes in PRT
due to PTA and change in heart rate. This shows that the
change in heart rate does not explain the changes between
the pre-treatment state and the follow-up visit.
IV. DISCUSSION
The results show that the lower limb PRT increases with the
PAD lesions compared with healthy subjects or contralateral
Table III
MULTIPLE LINEAR REGRESSION COEFFICIENTS (β) WITH P-VALUES FOR
UPPER AND LOWER LIMB PRTS. STATISTICALLY SIGNIFICANT (p < 0.05)
VALUES ARE HIGHLIGHTED.
Lower limb Upper limb
β p β p
(Intercept, ms) 244 1.7 · 10−7 173 1.3 · 10−8
Age (ms/year) 0.63 0.015 1.4 5.7 · 10−9
Heart rate (ms/bpm) -1.3 0.002 -1.1 0.005
PAD (ms) 42 4.2 · 10−4 16 0.513
Diabetes (ms) 15 0.256 -11 0.440
Dyslipidemia (ms) 47 0.006 0.93 0.947
Smoking (ms) 1.0 0.917 22 0.018
Rheumatoid arthritis (ms) -11 0.513 24 0.050
Intermittent claudication (ms) 46 0.002 4.0 0.855
Hypertension (ms) -44 0.003 12 0.343
Coronary artery disease (ms) -14 0.556 11 0.642
Coronary thrombosis (ms) -18 0.510 -34 0.273
Cardiac failure (ms) 7.0 0.720 -16 0.412
Arrhythmia (ms) 45 0.101 25 0.337
F-statistics vs. constant model 5.3·10−17 7.4·10−11
PAD = peripheral arterial disease
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MULTIPLE LINEAR REGRESSION COEFFICIENTS (β) WITH P-VALUES
BETWEEN PRE-TREATMENT CONDITION AND FOLLOW-UP VISIT FOR THE
CHANGES IN UPPER LIMB PRTS WITH CHANGE IN HEART RATE (HR) AND
PTA AS PREDICTORS. STATISTICALLY SIGNIFICANT (p < 0.05) VALUES
ARE HIGHLIGHTED.
β p
(Intercept, ms) -2.9 0.73
Change in HR (ms/bpm) -0.94 0.29
PTA (ms) -55.4 3.3 · 10−05
F-statistics vs. constant model 9.9·10−5
healthier lower limb. The differences between the contralateral
lower limbs in the PAD-patients are clearly smaller than
between the limb with PAD lesions and healthy same-aged
control subjects. An obvious reason is that the PAD lesions are
often bilaterally present. In this study, the ABI measurements
of the non-treated lower limb provided conflicting readings
in the two measurements: 68 % of the PAD-patients had
abnormal ABI also in the non-treated lower limb at least in
one of the two ABI measurements (ABI before the PTA and
during the follow-up visit) which supports our observation
of bilaterality. This is a limitation of the study as the con-
clusions from the condition of the non-treated asymptomatic
or healthier lower limb are not necessarily reliable due to
the challenges with the current reference methods [4], [5].
However, the distributions of the ABI-readings of the treated
and non-treated lower limbs were (Table I) more distinct than
the corresponding distributions of the PRTs (Fig. 2) and the
other reference value, toe pressure (Table I).
A notable issue at group-level is that the PRT differences
between the follow-up visit condition and the old control
subjects remain (Fig. 2), despite the PTA treatment and the
resulting trend towards smaller PRTs. This difference is also
seen in ABI-readings (Table I). The major reason most likely
is in the systemic nature of atherosclerosis. In the PTA of
the SFA, only the most stenosed or occluded segments of the
SFA are dilated, and the possible lesions in the more distal
segments of the lower limb arteries are left untreated.
The index finger PRTs do not change consistently between
the different measurements within the PAD-patients. In gen-
eral, the stenoses in the upper limbs are less common than in
the lower limbs [17], [18]. The small differences observed in
the index finger PRTs between the old control subjects and
PAD-patients before the PTA are assumed to be caused by
excessive arterial stiffening which is typical with the PAD-
patients having several cardiovascular risk factors. The stiff-
ening of the arteries increases the pulse wave velocity which
makes the heart-beat induced wave and first reflected wave
more and more overlapping, causing delayed temporal location
of the peak value compared with the healthy arteries having
more distinct waves. Differences in other upper limb PW-
derived features, such as augmentation index and reflection
index, between healthy controls and atherosclerotic patients
have also been observed in an earlier study [19].
According to the presented results, the upper limb PRTs are
mainly associated with the aging (1.4 ms/year, p ≈ 5.7 ·10−9)
and history of smoking (22 ms, p ≈ 0.018). Also the
lower limb PRTs depend slightly on the age (0.63 ms/year,
p ≈ 0.015), but PAD (42 ms, p ≈ 4.2 · 10−4) and its
typical symptoms, such as intermittent claudication (46 ms,
p ≈ 0.002) and dyslipidemia (47 ms, p ≈ 0.006), were
found to have a more significant effect. Based on the presented
results, the lower limb PW-derived features are more sensitive
than the upper limb PWs to reveal arterial diseases which can
be clinically seen as a continuum of degenerative changes.
One possible reason is that the higher hydrostatic pressure
in the lower limbs at standing or sitting positions causes
physiological thickening of the arterial walls, making the
arteries of the lower limb more vulnerable to atherosclerotic
changes [20]. On the other hand, the arterial pathway from the
heart to the toe is longer than distance from the heart to the
finger which may have an effect, too.
Earlier studies have found association between age and PTT
[8]–[10] as well as association between the time delays of
pulse arrivals between healthy and diseased lower limbs [11].
In both cases, peak or foot points of the PW are utilized as ref-
erence points. A recent study [12] suggests that the PTA affects
positively to the lower limb PTT of a treated limb. There are
also studies reporting differences in the PRTs between PAD-
patients who have abnormal ABI and healthy control subjects
as well as differences between the contralateral lower limbs of
the PAD-patients [7]–[9]. However, the authors are not aware
of the prior studies reporting the changes of PRT caused by
the PTA treatment. The present study shows that the PRTs
decrease towards healthier values as a result of successful PTA.
The positive changes found in the vascular dynamics as a result
of the PTA are supported also by Yokoyama et al. [21] who
have reported a decrease in brachial-ankle pulse wave velocity
(baPWV) in diabetic patients having PAD compared with
diabetic patients without PAD lesions even though baPWV
normally increases with age and arterial stiffening. In their
study, an increase in baPWV values of the diabetic patients
was observed after the successful PTA. A positive change
after the lower limb PTA in an upper limb derived vascular
parameter, radial artery derived aortic augmentation index,
has been reported as a result of beneficial systemic vascular
effects after revascularization and remodeling [22]. However,
the present study did not find consistent improvement in the
upper limb PRT or non-treated lower limb PRT.
When considering the pressure as a driving force or input
in the arterial system, arterial tree as a conduit system or a
transfer function having a certain frequency response, and the
observed peripheral blood volume pulse as an output or a
response of the system, the increase in the flow resistance
of the arterial pathway decreases the cut-off frequency of
the arterial tree. This causes higher-frequency features to be
attenuated which is seen as rounded features of the PW and
the delays in the response of the system, i.e. the arrival
of the peripheral peak blood volume in the case of PPG
measurement. The dimininished arterial compliance, which is
associated with aging, decreases the PTT by 0.58 ms/year
. . .0.80 ms/year [7], [10], but PAD increases in the lower limb
PRT and foot- and peak point-based PTTs with PAD-patients
[8], [9], [12] which is in line with the present results and our
assumption. With respect to the present and earlier results, the
8increase in flow resistance is a dominating factor compared
with the decreases in the arterial compliance in PAD-patients.
Previous studies have reported varying sensitivity of 15%–
79% and specificity of 83%–99% for a test of ABI< 0.9 [5],
which is the current gold standard in daily clinical practice
in screening and monitoring of the PAD. ABI has challenges
especially in the patients having mediasclerotic changes. In
such patients, normal or too high ABI readings are expected,
despite the stenoses, since the stiffening of the lower limb
arteries prevents the compression of the arteries with a cuff
used in the ABI measurement. Lower limb PRT or other
lower limb PW-derived markers [8], [9], [11], [16], [19] could
play an additional diagnostic role along with conventional
screening tools such as ABI and toe pressure measurement
especially in patients having stenoses and mediasclerotic
changes concomitantly present in the lower limbs. As the PRT
is not significantly disturbed from the inserted endovascular
instrumentation, it could be suitable even for peri-operative
monitoring to check the patient’s response to the treatment.
However, the validation of the method requires further studies
with higher sample size and especially diabetic patients having
ABI>1.3.
V. CONCLUSIONS
The present proof-of-concept study suggests that lower
limb PRT is an effective marker of PAD lesions. Based on
the data recorded from 89 Caucasian subjects, the lower
limb PRT greater than approximately 240 ms indicates PAD
lesions and the patients may benefit from additional vascular
examinations. The age does not explain the difference, and
the method is selective (AUC=0.986) for the PAD lesions in
the lower limb: The study showed that there were immediate
changes (-33.9 ms (-74.6 ms. . . -4.2 ms), p < 0.0005) of the
lower limb PRTs in the limb that underwent PTA of the SFA,
and the changes became more visible (-64.7 ms (-137.3 ms. . . -
20.1 ms), p < 0.0005) after one month follow-up period, most
probably due to histological remodeling of the lower limb
arteries after the revascularization. In the case of non-treated
lower limb or upper limb, no consistent changes were observed
in the PRT. Based on the present and previous studies, lower
limb PW-derived features [8], [9], [12], [16], [19] could add
to diagnostics especially in patients presenting with stenoses
and mediasclerotic changes of the lower limb arteries. Despite
the promising results, further studies with higher sample sizes
should confirm and validate the results.
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